Warning: Last items in stock!
Availability date:
TNFSF14 Mouse
Recipient :
* Required fields
or Cancel
Formulation | TNFSF14 protein was lyophilized from a 0.2um filtered concentrated solution in PBS pH7.4. |
Solubility | It is recommended to reconstitute the lyophilized TNFSF14 in sterile 100mM HAc not less than 100ug/ml, which can then be further diluted to other aqueous solutions. |
Purity | Greater than 96.0% as determined by: (a) Analysis by RP-HPLC.(b) Analysis by SDS-PAGE. |
Description | TNFSF14 Mouse Recombinant produced in E. Coli is a single, non-glycosylated, polypeptide chain containing 168 amino acids and having a molecular mass of 18.4kDa. |
Protein Background | TNFRSF14, a member of the TNF receptor superfamily, is a type I transmembrane protein. TNFRSF14 is expressed in peripheral blood T cells, B cells, monocytes and in various tissues enriched in lymphoid cells. TNFRSF14 operates as a co-stimulatory factor for the activation of lymphoid cells and as a deterrent to infection by herpesvirus. Additionally, TNFRSF14 encourages the proliferation of T cells, and triggers apoptosis of various tumor cells. |
Expression host | Escherichia Coli. |
Synonyms | Tumor necrosis factor ligand superfamily member 14, CD258, Tnfsf14, Light. |
Reagent Appearance | Sterile Filtered White lyophilized (freeze-dried) powder. |
Stability | Lyophilized TNFSF14 although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution TNFSF14 should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles. |
Amino acid sequence | DGGKGSWEKL IQDQRSHQAN PAAHLTGANA SLIGIGGPLL WETRLGLAFL RGLTYHDGAL VTMEPGYYYV YSKVQLSGVG CPQGLANGLP ITHGLYKRTS RYPKELELLV SRRSPCGRAN SSRVWWDSSF LGGVVHLEAG EEVVVRVPGN RLVRPRDGTR SYFGAFMV. |
Biological Activity | The ED50 as determined by a cytotoxicity assay using human HT-29 cells is less than 2ug/ml, corresponding to a specific activity of > 500 IU/mg in the presence of murine anti-polyHistidine monoclonal antibody and rHuIFN-g. |